|
25590
|
Groeihormooncurve ZMC
Panel
|
|
Serum (9×) |
|
|
–
|
—
|
—
|
› |
|
25570
|
Groeihormoon-curve 10 pt.
Panel
|
|
Serum (10×) |
|
10 (0,4) |
–
|
—
|
—
|
› |
|
25550
|
Groeihormoon-curve 5 pt.
Panel
|
|
Serum (5×) |
|
29 (1,2) |
–
|
—
|
—
|
› |
|
25530
|
ACTH-curve
Panel
ACTH-curve, Corticotropine-curve
|
|
EDTA (9×) |
|
|
–
|
—
|
58560-4
|
› |
|
25470
|
LH-curve B
Panel
LH curve
|
|
Serum (4×) |
|
|
–
|
—
|
—
|
› |
|
25429
|
Cortisol curve (2p)
Panel
|
|
Serum (2×) |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
25420
|
Cortisol-curve B
Panel
Synacthenstimulatietest
|
|
Serum (3×) |
|
3 (0,1) |
–
|
—
|
—
|
› |
|
25390
|
Prolactine-curve
Panel
Prolactine - Thyrotropin Releasing Hormone stimulatie - curve
|
|
Serum (6×) |
|
39 (1,6) |
–
|
—
|
—
|
› |
|
25360
|
TSH-curve
Panel
|
|
Serum (4×) |
|
|
–
|
—
|
—
|
› |
|
25200
|
C-peptide curve
Panel
|
|
Serum (5×) |
|
8 (0,3) |
–
|
101410-9
|
—
|
› |
|
25130
|
Insuline curve (10p)
Panel
|
|
Serum (7×) |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
25110
|
Insuline bij GTT
Panel
|
|
Serum (5×) |
|
46 (1,9) |
–
|
50673-3
|
—
|
› |
|
25104
|
Insuline index (HOMA)
Panel
FIRI, HOMA index, Insuline resistentie index
|
|
Glucose (Fluoridebuis), Serum (2×) |
|
67 (2,8) |
–
|
—
|
—
|
› |
|
25053
|
AMH
Panel
AMH, Müllerian inhibiting factor (MIF), Müllerian inhibiting hormone (MIH)
|
|
Serum |
|
23 (1) |
–
|
—
|
—
|
› |
|
25044
|
Cortisol + uur afname
Panel
|
|
Serum |
|
2 (0,1) |
–
|
83088-5
|
83090-1
|
› |
|
25041
|
Vrij plasmacortisol
Panel
|
|
Serum |
|
99 (4,1) |
–
|
2145-1
|
—
|
› |
|
25028
|
Macroprolactine
Panel
Prolactine na PEG-precipitatie
|
|
Serum |
|
68 (2,9) |
–
|
78984-2
|
—
|
› |
|
24960
|
Down 2° trim.(13-18w)
Panel
|
|
Serum |
|
482 (20,1) |
–
|
35086-8
|
—
|
› |
|
24959
|
Down 1e trim.(9-12,6w)
Panel
|
|
Serum |
|
482 (20,1) |
–
|
—
|
—
|
› |
|
24653
|
Enterovirus antistoffen
Panel
Coxsackievirus As, Echovirus As, Enterovirus As
|
|
Serum |
|
308 (12,8) |
–
|
—
|
—
|
› |
|
24647
|
Ratio SARS-CoV-2 S/N IgG
Panel
Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome
|
|
Serum (2×) |
|
72 (3) |
–
|
—
|
—
|
› |
|
24585
|
HSV type 1-2 immunoblot
Panel
Herpes simplex IgG type 1, Herpes simplex IgG type 2, HSV IgG type 1-2 differentiatie
|
|
Serum |
|
257 (10,7) |
–
|
81621-5
|
—
|
› |
|
24574
|
Rubella bevestiging
Panel
|
|
Serum |
|
20 (0,8) |
–
|
—
|
—
|
› |
|
24469
|
HBsAg confirmatie
Panel
Hepatitis B s Ag neutralisatie
|
|
Serum |
|
42 (1,8) |
–
|
63557-3
|
—
|
› |
|
24455
|
Neospora canine
Panel
Neospora (hond)
|
|
Serum |
|
163 (6,8) |
–
|
—
|
—
|
› |
|
24435
|
Legionella pneumon.
Panel
|
|
Serum |
|
305 (12,7) |
–
|
—
|
—
|
› |
|
24428
|
CMV IgG zw./infectie?
Panel
CMV IgG (zwanger/infectie?)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24426
|
CMV IgM zw./infectie?
Panel
CMV IgM (zwanger/infectie?)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24425
|
Toxo IgG zw./infectie?
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24424
|
Toxo IgM zw./infectie?
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24423
|
CMV IgG zwanger
Panel
CMV IgG (zwanger)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24422
|
CMV IgM zwanger
Panel
CMV IgM (zwanger)
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24421
|
Toxoplasma IgG zwanger
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24420
|
Toxoplasma IgM zwanger
Panel
Toxoplasmose
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
|
24393
|
Leptospirose Profiel
Panel
|
|
Serum, EDTA, Urine |
|
160 (6,7) |
–
|
—
|
—
|
› |
|
24371
|
Toxoplasma confirm. AML
Panel
Toxoplasmose
|
|
Serum |
|
164 (6,8) |
–
|
—
|
—
|
› |
|
24364
|
Toxoplasmose dier
Panel
Toxoplasma IgG (veterinair), Toxoplasma IgM (veterinair), Toxoplasmose
|
|
Serum |
|
113 (4,7) |
–
|
—
|
—
|
› |
|
24358
|
Toxo IgG aviditeit
Panel
Toxoplasmose
|
|
Serum |
|
407 (17) |
–
|
34422-6
|
—
|
› |
|
24110
|
Salmonella (Widal)
Panel
Widal
|
|
Serum |
|
6 (0,2) |
–
|
98211-6
|
—
|
› |
|
23332
|
Anti-beta2 glycoproteïne
Panel
|
|
Serum |
|
57 (2,4) |
–
|
—
|
—
|
› |
|
23320
|
Huid as confirmatie
Panel
Basale membraan van de huid antistoffen confirmatie, Huid-antistoffen confirmatie, Keratinocyten antistoffen confirmatie
|
|
Serum |
|
808 (33,7) |
–
|
—
|
—
|
› |
|
23285
|
AMA-M2 ...
Panel
AMA-M2, Anti-lever Antistoffen, Anti-LKM
|
|
Serum |
|
186 (7,7) |
–
|
85092-5
|
—
|
› |
|
23260
|
ANCA/MPO/PR3 diagnose
Panel
Anti-MPO, Anti-Myeloperoxidase, Anti-PR3
|
|
Serum |
|
65 (2,7) |
–
|
46266-3
|
—
|
› |
|
23160
|
ENA (identificatie)
Panel
Autoantistof identificatie, ENA
|
|
Serum |
|
66 (2,7) |
–
|
95267-1
|
—
|
› |
|
23075
|
Lactaatcurve (punt 1-12)
Panel
Melkzuur curve
|
|
Glucose (Fluoridebuis) (12×) |
|
|
–
|
—
|
—
|
› |
|
22935
|
Vrije lichte ketens K/L
Panel
Freelite
|
|
Serum |
|
80 (3,3) |
–
|
57778-3
|
—
|
› |
|
22895
|
C1-esterase inhibitor
Panel
C1INH (activiteit)
|
|
Citraat |
|
184 (7,7) |
–
|
10634-4
|
—
|
› |
|
22833
|
IgD + info
Panel
Immuunglobuline D
|
|
Serum |
|
217 (9,1) |
–
|
56688-5
|
—
|
› |
|
22778
|
VEGF
Panel
Vascular Endothelial Growth Factor, VEGF, VEGF165
|
|
Serum, EDTA |
|
743 (31) |
–
|
—
|
—
|
› |
|
22767
|
Foliumzuur in RBC
Panel
|
|
Serum |
|
2 (0,1) |
–
|
—
|
—
|
› |
